{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:45:48Z","timestamp":1778863548391,"version":"3.51.4"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Romanian Ministery of Research and Innovation, CNCS \u2013 UEFISCDI","award":["PN-III-P1-1.1-TE-2016-1054"],"award-info":[{"award-number":["PN-III-P1-1.1-TE-2016-1054"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.neubiorev.2019.03.022","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T18:08:21Z","timestamp":1553537301000},"page":"32-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Biological markers evaluated in randomized trials of psychological treatments for depression: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"101","author":[{"given":"Ioana A.","family":"Cristea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Karyotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Hollon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim","family":"Cuijpers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Gentili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2019.03.022_bib0005","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/1359105314550350","article-title":"Effects of psychotherapy in combination with pharmacotherapy, when compared to pharmacotherapy only on blood pressure, depression, and anxiety in female patients with hypertension","volume":"21","author":"Ahmadpanah","year":"2016","journal-title":"J. Health Psychol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0010","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jpsychires.2009.05.006","article-title":"Does improving mood in depressed patients alter factors that may affect cardiovascular disease risk?","volume":"43","author":"Barr Taylor","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1037\/abn0000049","article-title":"Attention bias modification for major depressive disorder: effects on attention bias, resting state connectivity, and symptom change","author":"Beevers","year":"2015","journal-title":"J. Abnorm. Psychol."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.03.022_bib0020","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1037\/0022-006X.55.4.550","article-title":"Group cognitive therapy and alprazolam in the treatment of depression in older adults","volume":"55","author":"Beutler","year":"1987","journal-title":"J. Consult Clin. Psychol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11682-015-9429-x","article-title":"How treatment affects the brain: meta-analysis evidence of neural substrates underpinning drug therapy and psychotherapy in major depression","volume":"10","author":"Boccia","year":"2016","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.31887\/DCNS.2015.17.3\/sbrooks","article-title":"A systematic review of the neural bases of psychotherapy for anxiety and related disorders","volume":"17","author":"Brooks","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0035","article-title":"Dejian mind-body intervention on depressive mood of community-dwelling adults: A randomized controlled trial","author":"Chan","year":"2011","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jad.2011.05.057","article-title":"Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies","volume":"134","author":"Cole","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/clpt.2013.221","article-title":"Pharmacogenomics in psychiatry: from therapeutic drug monitoring to genomic medicine","volume":"95","author":"Crettol","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cpr.2015.08.003","article-title":"The effects of cognitive behavior therapy for adult depression on dysfunctional thinking: a meta-analysis","volume":"42","author":"Cristea","year":"2015","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/wps.20346","article-title":"How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence","volume":"15","author":"Cuijpers","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/16506073.2017.1420098","article-title":"Who benefits from psychotherapies for adult depression? A meta-analytic update of the evidence","volume":"47","author":"Cuijpers","year":"2018","journal-title":"Cogn. Behav. Ther."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0065","unstructured":"Cuijpers, P., Reijnders, M., Karyotaki, E., (Under review). Psychological treatment of depression: An updated meta-analytic database of randomized trial. BMC Psychiatry."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ije\/dyp174","article-title":"How to assess the external validity of therapeutic trials: a conceptual approach","volume":"39","author":"Dekkers","year":"2009","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0080","first-page":"18","article-title":"Infection, depression, and immunity in women after coronary artery bypass: a pilot study of cognitive behavioral therapy","volume":"13","author":"Doering","year":"2007","journal-title":"Altern. Ther. Health Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0085","doi-asserted-by":"crossref","first-page":"479","DOI":"10.31887\/DCNS.2014.16.4\/bdunlop","article-title":"Neuroimaging-based biomarkers for treatment selection in major depressive disorder","volume":"16","author":"Dunlop","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0090","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/appi.ajp.2016.16050518","article-title":"Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder","volume":"174","author":"Dunlop","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/dme.13173","article-title":"The 6-month effectiveness of Internet-based guided self-help for depression in adults with Type 1 and 2 diabetes mellitus","author":"Ebert","year":"2017","journal-title":"Diabet. Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.76","article-title":"Immunological effects of behavioral activation with exercise in major depression: an exploratory randomized controlled trial","volume":"7","author":"Euteneuer","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/01674820412331282231","article-title":"Massage therapy effects on depressed pregnant women","volume":"25","author":"Field","year":"2004","journal-title":"J. Psychosom. Obstet. Gynaecol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0110","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.earlhumdev.2013.04.006","article-title":"Peer support and interpersonal psychotherapy groups experienced decreased prenatal depression, anxiety and cortisol","volume":"89","author":"Field","year":"2013","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.msard.2015.10.004","article-title":"Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis","volume":"5","author":"Fiest","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0120","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3758\/s13415-017-0540-x","article-title":"Brief training in mindfulness may normalize a blunted error-related negativity in chronically depressed patients","volume":"17","author":"Fissler","year":"2017","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jad.2017.10.049","article-title":"Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder","volume":"233","author":"Fonseka","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/neu.2015.41","article-title":"Cognitive behavioural therapy for depression: systematic review of imaging studies","volume":"28","author":"Franklin","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0135","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/jamainternmed.2015.5220","article-title":"Cognitive behavior therapy for depression and self-care in heart failure patients a randomized clinical trial","volume":"175","author":"Freedland","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0140","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3109\/09540261.2013.816657","article-title":"Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment","volume":"25","author":"Frieling","year":"2013","journal-title":"Int. Rev. Psychiatry (Abingdon, England)"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2008.04.033","article-title":"Neural responses to sad facial expressions in major depression following cognitive behavioral therapy","volume":"64","author":"Fu","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psychres.2015.06.009","article-title":"Examining the role of neuroinflammation in major depression","volume":"229","author":"Furtado","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0155","first-page":"6","article-title":"Why do we keep failing in identifying reliable biological markers in depression?","volume":"17","author":"Gentili","year":"2017","journal-title":"J. Evid. Psychother."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cpp.1817","article-title":"Treatment response in type 2 diabetes patients with major depression","volume":"21","author":"Gois","year":"2014","journal-title":"Clin. Psychol. Psychother."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0269881109102770","article-title":"Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy","volume":"24","author":"Harley","year":"2010","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0175","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0269881109102770","article-title":"Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy","volume":"24","author":"Harley","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0180","series-title":"METAN: Stata Module for Fixed and Random Effects Meta-analysis","author":"Harris","year":"2010"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0033291712000955","article-title":"Cortisol and depression: three questions for psychiatry","volume":"43","author":"Herbert","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0190","series-title":"Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration","author":"Higgins","year":"2011"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0195","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0200","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0205","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1177\/0269881110376691","article-title":"Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2\/3 receptors in major depressive disorder studied with [11C]raclopride PET","volume":"25","author":"Hirvonen","year":"2011","journal-title":"J. Psychopharmacol. (Oxford, England)"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11011-013-9462-7","article-title":"Mindfulness based cognitive therapy may improve emotional processing in bipolar disorder: pilot ERP and HRV study","volume":"29","author":"Howells","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000321558","article-title":"The long-term effects of psychotherapy added to pharmacotherapy on morning to evening diurnal cortisol patterns in outpatients with major depression","volume":"80","author":"Hsiao","year":"2011","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.genhosppsych.2013.10.019","article-title":"Efficacy of psychotherapy on diurnal cortisol patterns and suicidal ideation in adjustment disorder with depressed mood","volume":"36","author":"Hsiao","year":"2014","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0225","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s11136-015-1165-6","article-title":"Effects of motivational enhancement therapy plus cognitive behaviour therapy on depressive symptoms and health-related quality of life in adults with type II diabetes mellitus: a randomised controlled trial","volume":"25","author":"Huang","year":"2016","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0230","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0235","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1440-1614.2001.01026.x","article-title":"Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline","volume":"36","author":"Joyce","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0240","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/da.22491","article-title":"The long-term efficacy of acute-phase psychotherapy for depression: a meta-analysis of randomized trials","volume":"33","author":"Karyotaki","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0245","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.biopsych.2009.12.012","article-title":"Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis","volume":"67","author":"Kemp","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0250","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1176\/ajp.2007.164.5.778","article-title":"Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial","volume":"164","author":"Kennedy","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0255","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/STROKEAHA.110.611434","article-title":"Response to psychosocial treatment in poststroke depression is associated with serotonin transporter polymorphisms","volume":"42","author":"Kohen","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0260","series-title":"METAEFF: Stata Module to Perform Effect Sizes Calculations for Meta-Analyses","author":"Kontopantelis","year":"2009"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0265","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2648.2010.05540.x","article-title":"Treating depression in diabetes patients: does a nurse-administered minimal psychological intervention affect diabetes-specific quality of life and glycaemic control? A randomized controlled trial","author":"Lamers","year":"2011","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0270","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.297.4.367","article-title":"Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial","volume":"297","author":"Lesperance","year":"2007","journal-title":"Jama"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12160-010-9232-2","article-title":"A randomized controlled trial of behavioral weight loss treatment versus combined weight loss\/depression treatment among women with comorbid obesity and depression","volume":"41","author":"Linde","year":"2011","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0280","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.2017.0029","article-title":"Is hemoglobin a1c the right outcome for studies of diabetes?","volume":"317","author":"Lipska","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0285","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-129-8-199810150-00005","article-title":"Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial","volume":"129","author":"Lustman","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0290","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1192\/bjp.bp.106.024729","article-title":"Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression","volume":"190","author":"Luty","year":"2007","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0295","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archpsyc.55.5.452","article-title":"Treatment of depressive symptoms in human immunodeficiency virus-positive patients","volume":"55","author":"Markowitz","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0300","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archpsyc.58.7.641","article-title":"Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings","volume":"58","author":"Martin","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0305","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2013.143","article-title":"Toward a neuroimaging treatment selection biomarker for major depressive disorder","volume":"70","author":"McGrath","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0310","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0005-7894(05)80311-9","article-title":"Dexamethasone suppression test and response to cognitive therapy and antidepressant medication","volume":"23","author":"McKnight","year":"1992","journal-title":"Behav. Ther."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074657","article-title":"Neural correlates of psychotherapy in anxiety and depression: a meta-analysis","volume":"8","author":"Messina","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0320","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0325","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1037\/0022-006X.69.6.942","article-title":"Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis","volume":"69","author":"Mohr","year":"2001","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0330","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archneur.58.7.1081","article-title":"Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis","volume":"58","author":"Mohr","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0335","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/1073191114524272","article-title":"An exploratory analysis of the factor structure of the Dysfunctional Attitude Scale-Form A (DAS)","volume":"21","author":"Moore","year":"2014","journal-title":"Assessment"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0340","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.2196\/jmir.7274","article-title":"Web-based cognitive behavior therapy for depression in people with diabetes mellitus: a randomized controlled trial","author":"Newby","year":"2017","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0345","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/HJR.0b013e3283030a97","article-title":"Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review","volume":"15","author":"Nolan","year":"2008","journal-title":"Eur. J. Cardiovasc. Prevent. Rehab."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0350","series-title":"HETEROGI: Stata Module to Quantify Heterogeneity in a Meta-Analysis","author":"Orsini","year":"2006"},{"issue":"37","key":"10.1016\/j.neubiorev.2019.03.022_bib0355","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ijo.2013.25","article-title":"Randomized controlled trial of behavioral treatment for comorbid obesity and depression in women: the Be Active Trial","volume":"2005","author":"Pagoto","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0360","doi-asserted-by":"crossref","first-page":"439","DOI":"10.31887\/DCNS.2008.10.4\/gipapakostas","article-title":"Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder","volume":"10","author":"Papakostas","year":"2008","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0365","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.11459","article-title":"Management of depression in rheumatoid arthritis: a combined pharmacologic and cognitive-behavioral approach","volume":"49","author":"Parker","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0370","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12160-012-9377-2","article-title":"A psychoeducational intervention (SWEEP) for depressed women with diabetes","volume":"44","author":"Penckofer","year":"2012","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0375","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-015-0881-0","article-title":"Combining behavioural activation with physical activity promotion for adults with depression: findings of a parallel-group pilot randomised controlled trial (BAcPAc)","author":"Pentecost","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0380","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2337\/dc14-1599","article-title":"Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the diabetes and depression (DAD) study: a randomized controlled multicenter trial","volume":"38","author":"Petrak","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0385","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1745-6215-10-78","article-title":"Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial","volume":"10","author":"Pibernik-Okanovic","year":"2009","journal-title":"Trials"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13063-015-0833-8","article-title":"Does treatment of subsyndromal depression improve depression-related and diabetes-related outcomes? A randomised controlled comparison of psychoeducation, physical exercise and enhanced treatment as usual","volume":"16","author":"Pibernik-Okanovic","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0395","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpsychires.2017.05.007","article-title":"BDNF Val66Met and childhood adversity on response to physical exercise and internet-based cognitive behavioural therapy in depressed Swedish adults","volume":"93","author":"Rahman","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0400","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.ophtha.2014.05.002","article-title":"Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial","volume":"121","author":"Rovner","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0012715","article-title":"A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals","volume":"28","author":"Safren","year":"2009","journal-title":"Health Psychol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0410","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1037\/a0028208","article-title":"Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial","volume":"80","author":"Safren","year":"2012","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0415","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/dc13-0816","article-title":"A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes","volume":"37","author":"Safren","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0420","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/S2352-3018(16)30053-4","article-title":"Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial","volume":"3","author":"Safren","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0425","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S1478951506060305","article-title":"Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects","volume":"4","author":"Savard","year":"2006","journal-title":"Palliat. Support. Care"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0430","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3102\/0034654313500826","article-title":"Meta-analysis with complex research designs:dealing with dependence from multiple measures and multiple group comparisons","volume":"84","author":"Scammacca","year":"2014","journal-title":"Rev. Educ. Res."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0435","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/00004714-198606000-00010","article-title":"Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression","volume":"6","author":"Schneider","year":"1986","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.sleep.2015.09.022","article-title":"Sleep quality changes in chronically depressed patients treated with mindfulness-based cognitive therapy or the cognitive behavioral analysissystem of psychotherapy: a pilot study","volume":"17","author":"Schramm","year":"2016","journal-title":"Sleep Medicine"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0445","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1007\/s10461-013-0538-5","article-title":"A preliminary RCT of CBT-AD for adherence and depression among HIV-positive Latinos on the U.S.-Mexico border: the Nuevo Dia study","volume":"17","author":"Simoni","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0450","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.2337\/dc13-2918","article-title":"Individual mindfulness-based cognitive therapy and cognitive behavior therapy for treating depressive symptoms in patients with diabetes: results of a randomized controlled trial","author":"Tovote","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0455","article-title":"Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","author":"Uchendu","year":"2016","journal-title":"Diabetic Med."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0460","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.psyneuen.2011.04.002","article-title":"Impact of a prenatal cognitive-behavioral stress management intervention on salivary cortisol levels in low-income mothers and their infants","volume":"36","author":"Urizar","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0465","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2337\/dc10-1248","article-title":"Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial","volume":"34","author":"van Bastelaar","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0470","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/NMD.0b013e3181a61594","article-title":"The effect of psychotherapy added to pharmacotherapy on cortisol responses in outpatients with major depressive disorder","volume":"197","author":"Yang","year":"2009","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0475","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-016-0200-9","article-title":"Measuring inter-rater reliability for nominal data - which coefficients and confidence intervals are appropriate?","volume":"16","author":"Zapf","year":"2016","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.neubiorev.2019.03.022_bib0480","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.11.036","article-title":"Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis","volume":"77","author":"Zorn","year":"2017","journal-title":"Psychoneuroendocrinology"}],"updated-by":[{"DOI":"10.1016\/j.neubiorev.2019.06.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000}}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763419300247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763419300247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T13:27:58Z","timestamp":1607002078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763419300247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":96,"alternative-id":["S0149763419300247"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.03.022","relation":{"has-preprint":[{"id-type":"doi","id":"10.31219\/osf.io\/xqfh9","asserted-by":"object"}]},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological markers evaluated in randomized trials of psychological treatments for depression: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}